Skip to Content

144 (Dutrebis lamivudine 150 mg / raltegravir 300 mg)

Generic Name: lamivudine/raltegravir

Pill imprint 144 has been identified as Dutrebis lamivudine 150 mg / raltegravir 300 mg.

Dutrebis is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Dutrebis lamivudine 150 mg / raltegravir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Dutrebis
Generic Name:
lamivudine/raltegravir
Imprint:
144
Strength:
lamivudine 150 mg / raltegravir 300 mg
Color:
Green
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Merck & Co., Inc.

More info Print Imprint Search

More about Dutrebis (lamivudine / raltegravir)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide